Attenuated and protease-profile modified sendai virus vectors as a new tool for virotherapy of solid tumors

HIGHLIGHTS

• who: Attenuated and colleagues from the Department of Internal Medicine I, Medical University Hospital, Tübingen, Germany, University Childrens Hospital, Tübingen, Germany, Department of Translational have published the article: Attenuated and Protease-Profile Modified Sendai Virus Vectors as a New Tool for Virotherapy of Solid Tumors, in the Journal: PLOS ONE | www.plosone.org of August/16,/2013
• what: The aim of this study was to develop a new generation of Sendai viruses exhibiting profound oncolytic activities while showing a highly attenuated phenotype in non-malignant cells. As SeV has a broad host range . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.